These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6366249

  • 1. ABH cell surface isoantigens in invasive bladder carcinoma associated with schistosomiasis.
    El Adl MM, Yamase HT, Nieh PT, Mostofa AS, Hinz CF, Walzak MP.
    J Urol; 1984 Feb; 131(2):249-51. PubMed ID: 6366249
    [Abstract] [Full Text] [Related]

  • 2. A modified immunoperoxidase method for the detection of ABH tissue isoantigens in patients with bladder carcinoma.
    Stul MS, Logghe GN, Bergmans GB, Vanvuchelen JK.
    Exp Pathol; 1985 Feb; 27(2):119-22. PubMed ID: 3888650
    [Abstract] [Full Text] [Related]

  • 3. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E, Rodriguez-Trinidad A, Blasco E, Torrado J, Lopez Garcia JA, Arozena F.
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [Abstract] [Full Text] [Related]

  • 4. [The study of the ABH isoantigen of bladder tumors].
    Fukatsu H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Takamura T, Yamada Y, Nishikawa E.
    Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrences.
    Stephenson TJ, Williams JL, Gelsthorpe K.
    Br J Urol; 1985 Apr; 57(2):148-53. PubMed ID: 3886066
    [Abstract] [Full Text] [Related]

  • 6. Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma.
    Malmström PU, Busch C, Norlen BJ, Andersson B.
    Scand J Urol Nephrol; 1988 Apr; 22(4):265-70. PubMed ID: 3238331
    [Abstract] [Full Text] [Related]

  • 7. Detection of blood group surface antigens of urinary bladder tumours using monoclonal antibodies with the avidin-biotin complex technique.
    Tan LB, Chiang C, Huang CH, Lin LM.
    Int Urol Nephrol; 1992 Apr; 24(3):255-64. PubMed ID: 1399382
    [Abstract] [Full Text] [Related]

  • 8. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern].
    Nasu Y, Kumon H, Matsumura Y, Ohmori H.
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400
    [No Abstract] [Full Text] [Related]

  • 9. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
    Malmström PU.
    Scand J Urol Nephrol Suppl; 1988 May; 112():1-55. PubMed ID: 3068792
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of flow-DNA analysis and cell surface isoantigens in carcinoma of bilharzial bladder.
    Shaaban AA, Javadpour N, Tribukait B, Ghoneim MA.
    Urology; 1992 Mar; 39(3):207-10. PubMed ID: 1546411
    [Abstract] [Full Text] [Related]

  • 11. [Studies on blood group isoantigens in uroepithelium. I. Determination of isoantigens in non-malignant epithelium of tumor-bearing bladder].
    Abe R.
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):1049-58. PubMed ID: 4079195
    [No Abstract] [Full Text] [Related]

  • 12. Isoantigens A, B and H in urinary bladder carcinomas following radiotherapy.
    Alroy J, Teramura K, Miller AW, Pauli BU, Gottesman JE, Flanagan M, Davisohn I, Weinstein RS.
    Cancer; 1978 May; 41(5):1739-45. PubMed ID: 647623
    [Abstract] [Full Text] [Related]

  • 13. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
    Wiley EL, Mendelsohn G, Droller MJ, Eggleston JC.
    J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
    [Abstract] [Full Text] [Related]

  • 14. Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens.
    Richie JP, Blute RD, Waisman J.
    J Urol; 1980 Jan; 123(1):22-4. PubMed ID: 6985979
    [Abstract] [Full Text] [Related]

  • 15. The prediction of invasive potential in superficial transitional cell carcinoma of the bladder.
    Finan PJ, Anderson JR, Doyle PT, Lennox ES, Bleehen NM.
    Br J Urol; 1982 Dec; 54(6):720-5. PubMed ID: 6758916
    [Abstract] [Full Text] [Related]

  • 16. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. II. Results of a long-term follow-up and technical problems].
    Kumon H, Nasu Y, Matsumura Y, Ohmori H.
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):731-8. PubMed ID: 6492527
    [No Abstract] [Full Text] [Related]

  • 17. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
    Nakatsu H, Kobayashi I, Onishi Y, Igawa M, Ito H, Tahara E, Nihira H.
    J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
    [Abstract] [Full Text] [Related]

  • 18. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA, Javadpour N, Worsham GF, O'Connell KJ.
    Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
    [Abstract] [Full Text] [Related]

  • 19. ABH isoantigens, histology and DNA ploidy in 36 consecutive patients with transitional cell bladder cancer. Status of tumor and biopsies taken from visually normal urothelium.
    Borgström E, Nyman C, Lönn M.
    Urol Res; 1987 Apr; 15(4):199-202. PubMed ID: 3672667
    [Abstract] [Full Text] [Related]

  • 20. The study on cell surface antigens in epithelial tumor of the upper urinary tract: ABH-isoantigen and Thomsen-Friedenreich antigen.
    Fukatsu H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Nishikawa E, Yamada Y, Satoh T.
    Hinyokika Kiyo; 1989 Jun; 35(6):949-54. PubMed ID: 2801395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.